Changes in inflammatory mediators in peri-implant fluid after implant insertion

Journal of Periodontology

Volumn 80, Issue 2, 2009, Pages 297-306

  Venza, Mario ^a   Visalli, Maria ^a   Lo Giudice, Giuseppe ^a   Cicciù, Marco ^a   Passi, Pietro ^b   Teti, Diana ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Arachidonic acid; Dental implants; Histamine; Inflammation; Titanium

Indexed keywords

AUTACOID; HISTAMINE; HYDROXYICOSATETRAENOIC ACID; LEUKOTRIENE B4; PROSTAGLANDIN E2;

ADULT; ARTICLE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTURE; FEMALE; GINGIVITIS; HUMAN; IMMUNOLOGY; LONGITUDINAL STUDY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; OSTEOLYSIS; PERIODONTICS; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; TOOTH IMPLANTATION; TOOTH PROSTHESIS;

ADULT; ALVEOLAR BONE LOSS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL PROSTHESIS, IMPLANT-SUPPORTED; DENTURE, PARTIAL, FIXED; DINOPROSTONE; FEMALE; GINGIVAL CREVICULAR FLUID; HISTAMINE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; INFLAMMATION MEDIATORS; LEUKOTRIENE B4; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERIODONTAL INDEX;

EID: 59649108884     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.080411     Document Type: Article

References (42)

1. Buser D, Belser UC, Lang NP. The original one-stage dental implant system and its clinical application. Periodontol 2000 1998;17:106-118.
2. Lekholm U, Gunne J, Henry P, et al. Survival of the Brånemark implant in partially edentulous jaws: A 10-year prospective multicenter study. Int J Oral Maxillofac Implants 1999;14:639-645.
3. Ferrigno N, Laureti M, Fanali S, Grippaudo G. A long-term follow-up study of nonsubmerged ITI implants in the treatment of totally edentulous jaws. Part I: Ten-year life table analysis of a prospective multicenter study with 1,286 implants. Clin Oral Implants Res 2002;13:260-273.
4. Ekelund JA, Lindquist LW, Carlsson GE, Jemt T. Implant treatment in the edentulous mandible: A prospective study on Brånemark system implants over more than 20 years. Int J Prosthodont 2003;16:602-608.
5. Meijer HJ, Raghoebar GM, Van't Hof MA, Visser A. A controlled clinical trial of implant-retained mandibular overdentures: 10 years' results of clinical aspects and aftercare of IMZ implants and Brånemark implants. Clin Oral Implants Res 2004;15:421-427.
6. Cecchinato D, Olsson C, Lindhe J. Submerged or nonsubmerged healing of endosseous implants to be used in the rehabilitation of partially dentate patients. J Clin Periodontol 2004;31:299-308.
7. Gotfredsen K, Rostrup E, Hjorting-Hansen E, Stoltze K, Budtz-Jorgensen F. Histological and histomorphometrical evaluation of tissue reactions adjacent to endosteal implants in monkeys. Clin Oral Implants Res 1991;2:30-37.
8. Abrahamsson I, Berglundh T, Wennstrom J, Lindhe J. The peri-implant hard and soft tissues at different implant systems. A comparative study in the dog. Clin Oral Implants Res 1996;7:212-219.
9. Ericsson I, Nilner K, Klinge B, Glantz PO. Radiographical and histological characteristics of submerged and nonsubmerged titanium implants. An experimental study in the Labrador dog. Clin Oral Implants Res 1996;7:20-26.
10. Boioli LT, Penaud J, Miller N. Meta-analytic, quantitative assessment of osseointegration establishment and evolution of submerged and non-submerged endosseous titanium oral implants. Clin Oral Implants Res 2001;12:579-588.
11. Malmstro̊m HS, Fritz ME, Timmis DP, Van Dyke TE. Osseo-integrated implant treatment of a patient with rapidly progressive periodontitis. A case report. J Periodontol 1990;61:300-304.
12. Fardal O, Johannessen AC, Olsen I. Severe, rapidly progressing peri-implantitis. J Clin Periodontol 1999;26:313-317.
13. Hasturk H, Kantarci A, Ebrahimi N, et al. Topical H2 antagonist prevents periodontitis in a rabbit model. Infect Immun 2006;74:2402-2414.
14. Tsai CC, Hong YC, Wu YM. Measurement of prostaglandin E2 and leukotriene B4 in the gingival crevicular fluid. J Dent 1998;26:97-103.
15. 2 regulates gingival mononuclear cell immunoglobulin production. J Periodontol 1995;66:222-227.
16. Venza M, Visalli M, Cucinotta M, Cicciù D, Passi P, Teti D. Salivary histamine level as a predictor of periodontal disease in type 2 diabetic and non-diabetic subjects. J Periodontol 2006;77:1564-1571.
17. Pradeep AR, Manjunath SG, Swati PP, Shikha C, Sujatha PB. Gingival crevicular fluid levels of leukotriene B4 in periodontal health and disease. J Periodontol 2007;78:2325-2330.
18. Czarnetzki BM, Rosenbach T. Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its v-oxidation products in vitro. Prostaglandins 1986;31:851-858.
19. Ternowitz T, Herlin T, Fogh K. Human monocyte and polymorphonuclear leukocyte chemotaxis and chemokinetic response to leukotriene B4 and FMLP. Acta Pathol Microbiol Immunol Scand [C] 1987;95:47-54.
20. Noguchi K, Ishikawa I. The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontol 2000 2007;43:85-101.
21. Offenbacher S, Odle BM, Gray RC, Van Dyke TE. Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients. J Periodontal Res 1984;19:1-13.
22. Offenbacher S, Odle BM, Van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res 1986;21:101-112.
23. Inaba H, Tagashira M, Honma D, et al. Identification of hop polyphenolic components which inhibit prostaglandin E2 production by gingival epithelial cells stimulated with periodontal pathogen. Biol Pharm Bull 2008;31:527-530.
24. Offenbacher S, Odle BM, Brasweell LD, et al. Changes in cyclooxygenase metabolites in experimental periodontitis in Macaca mulatta. J Periodontal Res 1989;24:63-74.
25. Tubb M, Williams FE, Frazier LW. Gingival crevicular fluid prostaglandins and gingival phospholipids lipids in experimentally-induced periodontitis in the dog. Arch Oral Biol 1990;35:529-533.
26. Dwarakanath RS, Sahar S, Lanting L, et al. Viral vector-mediated 12/15-lipoxygenase overexpression in vascular smooth muscle cells enhances inflammatory gene expression and migration. J Vasc Res 2008;45:132-142.
27. Kowal-Bielecka O, Kowal K, Distler O, et al. Cyclooxygenase-and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: An imbalance between proinflammatory and anti-inflammatory lipid mediators. Arthritis Rheum 2005;52:3783-3791.
28. Ternowitz T, Fogh K, Kragballe K. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of polymorphonuclear leukocytes. Skin Pharmacol 1988;1:93-99.
29. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-551.
30. Löe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol 1967;38:610-616.
31. Machtei EE, Oved-Peleg E, Peled M. Comparison of clinical, radiographic and immunological parameters of teeth and different dental implant platforms. Clin Oral Implants Res 2006;17:658-665.
32. Eberhard J, Jepsen S, Albers HK, Acil Y. Quantitation of arachidonic acid metabolites in small tissue biopsies by reversed-phase high-performance liquid chromatography. Anal Biochem 2000;280:258-263.
33. Bradley JW. Distribution-Free Statistical Tests. London: Prentice-Hall; 1968:68-86.
34. Astrand P, Engquist B, Anzén B, et al. Nonsubmerged and submerged implants in the treatment of the partially edentulous maxilla. Clin Implant Dent Relat Res 2002;4:115-127.
35. Astrand P, Engquist B, Anzén B, et al. A three-year follow-up report of a comparative study of ITI Dental Implants and Brånemark System implants in the treatment of the partially edentulous maxilla. Clin Implant Dent Relat Res 2004;6:130-141.
36. Abrahamsson I, Berglundh T, Moon IS, Lindhe J. Peri-implant tissues at submerged and non-submerged titanium implants. J Clin Periodontol 1999;26:600-607.
37. Preshaw PM, Heasman PA. Prostaglandin E2 concentrations in gingival crevicular fluid: Observations in untreated chronic periodontitis. J Clin Periodontol 2002;29:15-20.
38. Offenbacher S, Collins JG, Arnold RR. New clinical diagnostic strategies based on pathogenesis of disease. J Periodontal Res 1993;28:523-535.
39. Goetzl EJ, Hill HR, Gorman RR. Unique aspects of the modulation of human neutrophil function by 12L-hydroperoxy-5,8,10,14-eicosatetraenoic acid. Prostaglandins 1980;19:71-85.
40. Sidhagen B, Hamberg M, Fredholm BB. Formation of 12L- hydroxyeicosatetraenoic acid (12-HETE) by gingival tissue. J Dent Res 1982;61:761-763.
41. Noguchi K, Morita I, Ishikawa I, Murota S. Impaired polymorphonuclear leukocyte 15-lipoxygenase activity in juvenile and rapidly progressive periodontitis. Prostaglandins Leukot Essent Fatty Acids 1988;33:137-141.
42. Jones AA, Cochran DL. Consequences of implant design. Dent Clin North Am 2006;50:339-360.